About Cytohesin-3
Cytohesin-3 (CYTH3) is a protein
from Homo sapiens identified by UniProt accession
O43739, 400 residues long.
MolForge cross-references it against 0 known binders and
62 disease associations.
Target properties
| Protein name | Cytohesin-3 |
| UniProt accession | O43739 |
| Gene | CYTH3 |
| Organism | Homo sapiens |
| Length | 400 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (62)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.35
- protein measurement · score 0.27
- platelet count · score 0.13
- insulin resistance · score 0.07
- neonatal intrahepatic cholestasis due to citrin deficiency · score 0.05
- Pallister-Hall syndrome · score 0.04
- LIPE-related familial partial lipodystrophy · score 0.04
- glycogen storage disease VI · score 0.04
- high density lipoprotein cholesterol measurement · score 0.04
- familial partial lipodystrophy, Kobberling type · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43739-F1 | alphafold | PREDICTED | 84.20 | — |
Amino-acid sequence (400 residues)
MDEDGGGEGG GVPEDLSLEE REELLDIRRR KKELIDDIER LKYEIAEVMT EIDNLTSVEE SKTTQRNKQI AMGRKKFNMD PKKGIQFLIE NDLLQSSPED VAQFLYKGEG LNKTVIGDYL GERDEFNIKV LQAFVELHEF ADLNLVQALR QFLWSFRLPG EAQKIDRMME AFASRYCLCN PGVFQSTDTC YVLSFAIIML NTSLHNHNVR DKPTAERFIA MNRGINEGGD LPEELLRNLY ESIKNEPFKI PEDDGNDLTH TFFNPDREGW LLKLGGGRVK TWKRRWFILT DNCLYYFEYT TDKEPRGIIP LENLSIREVE DPRKPNCFEL YNPSHKGQVI KACKTEADGR VVEGNHVVYR ISAPSPEEKE EWMKSIKASI SRDPFYDMLA TRKRRIANKK
Explore Cytohesin-3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets